A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy
Status:
Completed
Trial end date:
2021-09-20
Target enrollment:
Participant gender:
Summary
This is a Phase 1, single-site, interventional clinical trial evaluating the safety and
efficacy of IS-002 intravenous (IV) injection for fluorescent identification and delineation
of the positive cancer margins and metastatic lymph nodes during prostatectomy surgery using
the da Vinci® X/Xi Surgical System with Firefly® Fluorescent Imaging.